Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kleincise is a private Boston-based medtech startup developing robotic and minimally invasive procedure solutions for cardiovascular care. Public descriptions indicate the company is focused on automated, on-beat robotic systems for interventional cardiology and other beating-heart procedures. Kleincise appears to be an early-stage company that has participated in startup and medtech accelerator ecosystems, including MassMEDIC IGNITE. Based on the limited public information available, it is best characterized as a health technology and medical device company rather than a therapeutics developer. No clinical-stage drug pipeline has been publicly disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kleincise.